These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24841851)

  • 1. Follicular progesterone elevations with ovulation induction for IVF.
    Kasum M; Simunić V; Vrčić H; Stanić P; Orešković S; Beketić-Orešković L
    Gynecol Endocrinol; 2014 Aug; 30(8):537-41. PubMed ID: 24841851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basal serum progesterone and history of elevated progesterone on the day of hCG administration are significant predictors of late follicular progesterone elevation in GnRH antagonist IVF cycles.
    Venetis CA; Kolibianakis EM; Bosdou JK; Lainas GT; Sfontouris IA; Tarlatzis BC; Lainas TG
    Hum Reprod; 2016 Aug; 31(8):1859-65. PubMed ID: 27301360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is measurement of progesterone level prior to FSH stimulation useful in GnRH-antagonist cycles?
    Listijono D; Kilani S; Tilia L; Garrett D; Chapman M
    Hum Fertil (Camb); 2015; 18(4):234-7. PubMed ID: 25997693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GnRH agonist versus GnRH antagonist in ovarian stimulation: the role of elevated peak serum progesterone levels.
    Orvieto R; Nahum R; Meltzer S; Liberty G; Anteby EY; Zohav E
    Gynecol Endocrinol; 2013 Sep; 29(9):843-5. PubMed ID: 23802563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early luteal phase endocrine profile is affected by the mode of triggering final oocyte maturation and the luteal phase support used in recombinant follicle-stimulating hormone-gonadotropin-releasing hormone antagonist in vitro fertilization cycles.
    Fatemi HM; Polyzos NP; van Vaerenbergh I; Bourgain C; Blockeel C; Alsbjerg B; Papanikolaou EG; Humaidan P
    Fertil Steril; 2013 Sep; 100(3):742-7. PubMed ID: 23806846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preovulatory progesterone rise during ovarian stimulation for IVF.
    Kasum M; Radakovic B; Simunic V; Oreškovic S
    Gynecol Endocrinol; 2013 Aug; 29(8):744-8. PubMed ID: 23745784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steroid receptor expression in late follicular phase endometrium in GnRH antagonist IVF cycles is already altered, indicating initiation of early luteal phase transformation in the absence of secretory changes.
    Papanikolaou EG; Bourgain C; Kolibianakis E; Tournaye H; Devroey P
    Hum Reprod; 2005 Jun; 20(6):1541-7. PubMed ID: 15705618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to ovulation trigger is correlated to late follicular phase progesterone levels: A hypothesis explaining reduced reproductive outcomes caused by increased late follicular progesterone rise.
    Friis Wang N; Skouby SO; Humaidan P; Andersen CY
    Hum Reprod; 2019 May; 34(5):942-948. PubMed ID: 30927415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follicular phase endocrine characteristics during ovarian stimulation and GnRH antagonist cotreatment for IVF: RCT comparing recFSH initiated on cycle day 2 or 5.
    Blockeel C; Sterrenburg MD; Broekmans FJ; Eijkemans MJ; Smitz J; Devroey P; Fauser BC
    J Clin Endocrinol Metab; 2011 Apr; 96(4):1122-8. PubMed ID: 21307142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of estradiol and progesterone levels during the late follicular stage on the outcome of GnRH antagonist protocols.
    Simon C; Moreau J; Gatimel N; Cohade C; Parinaud J; Leandri R
    Gynecol Endocrinol; 2019 Jun; 35(6):481-484. PubMed ID: 30600726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progesterone change in the late follicular phase affects pregnancy rates both agonist and antagonist protocols in normoresponders: a case-controlled study in ICSI cycles.
    Demir B; Kahyaoglu I; Guvenir A; Yerebasmaz N; Altinbas S; Dilbaz B; Dilbaz S; Mollamahmutoglu L
    Gynecol Endocrinol; 2016; 32(5):361-5. PubMed ID: 26654315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subtle progesterone rise in the single-dose gonadotropin-releasing hormone antagonist (cetrorelix) stimulation protocol in patients undergoing in vitro fertilization or intracytoplasmic sperm injection cycles.
    Seow KM; Lin YH; Huang LW; Hsieh BC; Huang SC; Chen CY; Chen PH; Tzeng CR; Hwang JL
    Gynecol Endocrinol; 2007 Jun; 23(6):338-42. PubMed ID: 17616858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progesterone elevation does not compromise pregnancy rates in high responders: a pooled analysis of in vitro fertilization patients treated with recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in six trials.
    Griesinger G; Mannaerts B; Andersen CY; Witjes H; Kolibianakis EM; Gordon K
    Fertil Steril; 2013 Dec; 100(6):1622-8.e1-3. PubMed ID: 24083873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introduction: Gonadotropin-releasing hormone agonist triggering of final follicular maturation for in vitro fertilization.
    Casper RF
    Fertil Steril; 2015 Apr; 103(4):865-6. PubMed ID: 25681856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stop GnRH-Agonist Combined with Multiple-Dose GnRH-Antagonist for Patients with Elevated Peak Serum Progesterone Levels Undergoing Ovarian Stimulation for IVF: A Proof of Concept.
    Orvieto R; Kirshenbaum M; Galiano V; Zilberberg E; Haas J; Nahum R
    Gynecol Obstet Invest; 2020; 85(4):357-361. PubMed ID: 32580194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of gonadotropin-releasing hormone agonist/recombinant follicle-stimulating hormone versus gonadotropin-releasing hormone antagonist/recombinant follicle-stimulating hormone on follicular fluid levels of adhesion molecules during in vitro fertilization.
    Fornaro F; Cobellis L; Mele D; Tassou A; Badolati B; Sorrentino S; De Lucia D; Colacurci N
    Fertil Steril; 2007 Jan; 87(1):39-47. PubMed ID: 17084393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are GnRH antagonists comparable to agonists for use in IVF?
    Huirne JA; Homburg R; Lambalk CB
    Hum Reprod; 2007 Nov; 22(11):2805-13. PubMed ID: 17872909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study.
    Humaidan P; Bredkjaer HE; Bungum L; Bungum M; Grøndahl ML; Westergaard L; Andersen CY
    Hum Reprod; 2005 May; 20(5):1213-20. PubMed ID: 15760966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Live birth rates after IVF are reduced by both low and high progesterone levels on the day of human chorionic gonadotrophin administration.
    Santos-Ribeiro S; Polyzos NP; Haentjens P; Smitz J; Camus M; Tournaye H; Blockeel C
    Hum Reprod; 2014 Aug; 29(8):1698-705. PubMed ID: 24939956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follicular fluid anti-Müllerian hormone and inhibin B concentrations: comparison between gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist cycles.
    Lee JR; Kim SH; Kim SM; Jee BC; Ku SY; Suh CS; Choi YM; Kim JG; Moon SY
    Fertil Steril; 2008 Apr; 89(4):860-7. PubMed ID: 18249372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.